AN2 Therapeutics names Cameron Trenor III as chief medical officer in initial beneficial ownership filing
ANTX•Form 3 names new chief medical officer
AN2 Therapeutics filed a Form 3 naming Cameron C. Trenor III as chief medical officer, dated Aug. 24, 2026.
